Reduction of Masseter Muscle Prominence After Treatment With OnabotulinumtoxinA: Results From a Phase 3 Double-Blind, Randomized, Placebo-Controlled Study Period in Europe

Toxicon 2026

View at publisher
Authors: Juan García-Gavín, Rodrigo Marques da Mota, Dario Bertossi, Martina J. Kerscher, Radina Denkova, Rene M. Hopfinger, Reva McCaskill, Grace Pan, Catherine Foley, Helena Pavicic
DOI: 10.1016/j.toxicon.2025.108752
Cited by: 0

Fields of Study & Subjects

Botulinum Toxin and Related Neurological Disorders Myofascial pain diagnosis and treatment Temporomandibular Joint Disorders

Publication details

Journal / source
Toxicon
Volume
271
Pages
108752–108752
Publication date
8 January 2026
Language
EN